POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 84 filers reported holding POINT BIOPHARMA GLOBAL INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,263,297 | -69.9% | 789,100 | -59.1% | 0.02% | -71.2% |
| Q2 2023 | $17,478,249 | -22.8% | 1,929,167 | -38.1% | 0.05% | -25.7% |
| Q1 2023 | $22,641,406 | -2.9% | 3,114,361 | -2.6% | 0.07% | -11.4% |
| Q4 2022 | $23,310,249 | -18.3% | 3,197,565 | -13.4% | 0.08% | -30.7% |
| Q3 2022 | $28,544,000 | +114.5% | 3,692,620 | +89.0% | 0.11% | +103.6% |
| Q2 2022 | $13,308,000 | +3849.0% | 1,954,229 | +4523.4% | 0.06% | +5500.0% |
| Q1 2022 | $337,000 | – | 42,268 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,312,523 | $18,431,000 | 4.36% |
| GREAT POINT PARTNERS LLC | 2,060,000 | $16,418,000 | 3.97% |
| RA Capital Management | 9,003,018 | $71,754,000 | 1.57% |
| JOHNSON & JOHNSON | 1,000,000 | $7,970,000 | 1.51% |
| BVF INC/IL | 3,367,826 | $26,842,000 | 1.07% |
| Boxer Capital, LLC | 2,500,000 | $19,925,000 | 1.02% |
| Sio Capital Management, LLC | 377,684 | $3,010,000 | 1.00% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,014,408 | $24,025,000 | 0.73% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 204,679 | $1,631,000 | 0.68% |
| Atom Investors LP | 60,103 | $479,000 | 0.22% |